Literature DB >> 9918906

Association of diabetes mellitus and chronic hepatitis C virus infection.

A L Mason1, J Y Lau, N Hoang, K Qian, G J Alexander, L Xu, L Guo, S Jacob, F G Regenstein, R Zimmerman, J E Everhart, C Wasserfall, N K Maclaren, R P Perrillo.   

Abstract

While patients with liver disease are known to have a higher prevalence of glucose intolerance, preliminary studies suggest that hepatitis C virus (HCV) infection may be an additional risk factor for the development of diabetes mellitus. To further study the correlation of HCV infection and diabetes, we performed a retrospective analysis of 1,117 patients with chronic viral hepatitis and analyzed whether age, sex, race, hepatitis B virus (HBV) infection, HCV infection, and cirrhosis were independently associated with diabetes. In addition, a case-control study was conducted to determine the seroprevalence of HCV infection in a cohort of 594 diabetics and 377 clinic patients assessed for thyroid disease. In the former study after the exclusion of patients with conditions predisposing to hyperglycemia, diabetes was observed in 21% of HCV-infected patients compared with 12% of HBV-infected subjects (P =.0004). Multivariate analysis revealed that HCV infection (P =.02) and age (P =.01) were independent predictors of diabetes. In the diabetes cohort, 4.2% of patients were found to be infected with HCV compared with 1.6% of control patients (P =.02). HCV genotype 2a was observed in 29% of HCV-RNA-positive diabetic patients versus 3% of local HCV-infected controls (P <.005). In conclusion, the data suggest a relatively strong association between HCV infection and diabetes, because diabetics have an increased frequency of HCV infection, particularly with genotype 2a. Furthermore, it is possible that HCV infection may serve as an additional risk factor for the development of diabetes, beyond that attributable to chronic liver disease alone.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9918906     DOI: 10.1002/hep.510290235

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  123 in total

Review 1.  Extrahepatic manifestations of chronic viral hepatitis.

Authors:  N T Pyrsopoulos; K R Reddy
Journal:  Curr Gastroenterol Rep       Date:  2001-02

Review 2.  Diabetes mellitus during interferon therapy for chronic viral hepatitis.

Authors:  Ali Mofredj; Mehran Howaizi; Denis Grasset; Henri Licht; Sylvie Loison; Bruno Devergie; Renato Demontis; Jean-François Cadranel
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

Review 3.  Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights.

Authors:  Gül Bahtiyar; John J Shin; Ayse Aytaman; James R Sowers; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

4.  Viruses and diabetes: is there something sweet about hepatitis C infection?

Authors:  A L Mason; G J Alexander
Journal:  Ochsner J       Date:  2001-07

5.  Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis.

Authors:  Shu-Chun Chuang; Yuan-Chin Amy Lee; Mia Hashibe; Min Dai; Tongzhang Zheng; Paolo Boffetta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05       Impact factor: 4.254

6.  The interaction between insulin resistance, liver fibrosis and early virological response in Egyptian patients with chronic hepatitis C.

Authors:  Dina Hazem Ziada; Sherif El Saadany; Mohamed Enaba; Medhat Ghazy; Azza Hasan
Journal:  Can J Gastroenterol       Date:  2012-06       Impact factor: 3.522

7.  Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults.

Authors:  Michael Reid; Yifei Ma; Rebecca Scherzer; Jennifer C Price; Audrey L French; Michael W Plankey; Carl Grunfeld; Phyllis C Tien
Journal:  AIDS       Date:  2017-01-28       Impact factor: 4.177

8.  Effect of branched-chain amino acid supplementation on insulin resistance and quality of life in chronic hepatitis C patients.

Authors:  Alicia Ocaña-Mondragón; José Antonio Mata-Marín; Mario Uriarte-López; Carolina Bekker-Méndez; Enrique Alcalá-Martínez; Rosa María Ribas-Aparicio; Luis Antonio Uribe-Noguéz; Dulce María Rodríguez-Galindo; María de La Luz Martínez-Rodríguez
Journal:  Biomed Rep       Date:  2017-11-03

9.  Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader
Journal:  World J Exp Med       Date:  2012-04-20

10.  Diabetes mellitus is associated with impaired response to antiviral therapy in chronic hepatitis C infection.

Authors:  Hesham M Elgouhari; Claudia O Zein; Ibrahim Hanouneh; Ariel E Feldstein; Nizar N Zein
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.